Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Having lived with and studied multiple myeloma since my diagnosis in 2/1994, I have learned that just about every aspect of how conventional oncology defines, researches and treats multiple myeloma is
Continue reading“Meta-regression analyses failed to demonstrate any association between CR or VGPR with either overall survival or progression-free survival both in patients receiving autologous stem cell transplant
Continue reading“Lenalidomide (Revlimid) induced a 72% reduction in the risk of progression to symptomatic disease in patients with smoldering multiple myeloma at 3 years” The challenge with pre-myeloma, Monoclonal
Continue readingMultiple Myeloma chemotherapy, causes short, long-term and late stage side effects. Chemotherapy-induced pain is central to the discussion of side effects if the patient wants to manage or even heal the
Continue readingChoose between conventional blood thinner therapies such as coumadin, plavix, aspirin, or non-conventional therapies such as green tea extract, omega 3 fatty acids or curcumin- I am a long-term multiple
Continue reading“Vitamin D deficiency is associated with reduced overall survival for patients with multiple myeloma (MM)…Vitamin D deficiency is increasingly recognized in association with autoimmune and
Continue reading“Myeloma cells disturb a normally balanced bone remodeling process. This imbalance of bone metabolism may cause osteopenic bones, focal osteo lytic lesions and clinical symptoms.” For the MM
Continue reading“Concurrent management of (bone damage) with approved therapies as well as evidence-based management of the MM with the most effective therapies early in the disease life-cycle itself might be the key
Continue reading“Cytogenetic abnormalities are found in most multiple myeloma (MM) patients. Although their prognostic value has been well studied, there are limited data on the association of primary cytogenetic
Continue reading“The challenge for those newly diagnosed Multiple Myeloma patients that achieve remission is that the toxicity of those therapies can cause life-threatening side effects to the patient’s blood,
Continue reading“Bortezomib with dexamethasone as first-line treatment for AL amyloidosis with renal involvement…in multiple myeloma or MGUS patients?” You’ve been diagnosed with multiple myeloma
Continue readingWe review the potential applications of n-acetyl cysteine to facilitate recovery after traumatic brain injury, cerebral ischemia, and in treatment of cerebrovascular vasospasm after subarachnoid hemorrhage I
Continue reading